Nivolumab and ipilimumab shows a significantly higher OS rate in nccRCC compared to standard of care

Analysis of dexamethasone-enhanced pre-medication in motixafortide-induced haematopoietic stem cell mobilisation for MM

Bispecific antibody therapy for lymphoma patients failing CAR T-Cell therapy

Teclistamab-based induction regimens demonstrate manageable safety and efficacy in patients with transplant-eligible NDMM

Pembrolizumab shows improvement in overall survival for clear cell renal cell carcinoma

Irradiation plus ADT with GnRH antagonist vs. GnRH agonist shows similar efficacy in high risk locally advanced PC

Demographics, characteristics, survival and outcomes in older, untreated, AML with NPM1 mutations or KMT2A rearrangements

Beat AML master trial update: A clinical trial for acute myeloid leukaemia

Study shows association between tumour KIM-1 gene (HAVCR1) expression and immune infiltrates in RCC

Guiding metastasis-directed therapy with different PET/CT radiotracers affects distant disease control in HSPC patients

Bladder cancer updates from the second half of 2024

30 minute infusion of isatuximab shows potential in newly diagnosed multiple myeloma